KalVista Pharmaceuticals Inc (KALV) Opciones

KALV 10Q expected July 5

KALV over $10

KALV new 52=week high

INSIDER PURCHASE / SYNDICATE

KALV - 10% OWNER Venrock Healthcare P 86,048 $14.618

KALV new 52 week high

KALV new 52 week high

I would not even buy the shares at $20.

All in puts!

Boom!

Killed it with puts today!

* * $KALV Video Chart 02-09-2021 * *

Link to Video - click here to watch the technical chart video

This company is a disaster...

The company is delinquent.

? lol

Profitability
Profit Margin 0.00%
Gross Profit (ttm) $-27.5M
EBITDA $-48.38M
Net Income Avi to Common (ttm) $-37.12M
Diluted EPS (ttm) -2.08

Book Value Per Share (mrq) $3.63

Going to keep diluting more and more

They are hemorrhaging money. Have pretty much zero revenue. They still have hundreds of millions to spend of your money until phase 3 and beyond.

Operating Margin (ttm) -905.50%

Management Effectiveness

Return on Assets (ttm) -32.60%
Return on Equity (ttm) -45.61%

Revenue  $5.4M
Revenue Per Share  $0.30

$KALV Kalvista Pharma Trend Break



Major Downtrend broken
Broken above 200ma
Volume increased
MACD reversed
RSi in bullish uptrend

News: $KALV KalVista Pharmaceuticals Appoints Daniel B. Soland to Board of Directors

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced today that Daniel Soland has been appointed to its Board of Directors effective immediately. Mr...

Find out more https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-appoints-daniel-b-soland-to-board-of-directors-8035190.html

News: $KALV KalVista Pharmaceuticals to Present at Needham Healthcare Conference

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will present at the Needham Healthcare Conference on Wednesday, April 10, 2019, a...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-to-present-at-needham-healthcare-conference-7939130.html

KALV buy 28.87



normal chart







log chart

News: $KALV KalVista Pharmaceuticals Reports Fiscal Third Quarter Results

– Oral Hereditary Angioedema (HAE) Candidate KVD900 Phase 2 Trial Progressing – – Intravitreal Diabetic Macular Edema (DME) Candidate KVD001 Phase 2 Trial Completion Expected H2 2019 – – Oral Plasma Kallikrein Inhibitor Candidate KVD824 Dosi...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-reports-fiscal-third-quarter-results-7846828.html

Where is everyone?

$17.85 !!


KALV

Sniffer rocket ship today!! Wheeee.

KALV

$15.50 now ~ keep rollin



$KALV

http://m.nasdaq.com/article/sv-life-sciences-advisers-llc-buys-kalvista-pharmaceuticals-sells-raptor-pharmaceutical-cm744623

$8.25 now ~ keep rollin

any positive news and volume will move this north

LIVE action starting !!!

watching close ~

The way this is dropping, there has to be a lawsuit over the sale of cash at 60% off.
Where are those ambulance chasing securities lawyers?

So when will CBYL holders be issued KALV common stock?

CBYL is now KALV with a 1:14 reverse stock split.

Be very careful for the next few days as until all or most of the CBYL shares are converted to KALV, the only sellers will be private Kal Vista investors, those who bought after the symbol change and professionals. The price is likely to be high until existing CBYL retail holders can sell their shares. In addition, the existing CBYL shares will only represent 20% of the O/S. 80% will be held by the private investors in KVAL.

$6.00

New Ticker symbol now: KALV

Correction : $5.49 PM

WOW - look at this $0,89---> $4,60

New Ticker name now : KALV

look at NASDAQ - PM

Apparently the merger deal was approved by a huge margin.

Still don't get it.

* * $CBYL Video Chart 11-21-16 * *

Link to Video - click here to watch the technical chart video

Attempting to break 0.72. GL to holders

We'll see how this goes. Hopefully back to over a dollar.

CBYL continuing its upward momentum pre-market.

* * $CBYL Video Chart 11-18-16 * *

Link to Video - click here to watch the technical chart video

Oh okay. Im still up for it even if it is a merger. Good thing volume picked up today.

New buyer? They're not being bought, they're merging with another company and selling their cash at a steep discount.

Maybe the large shareholders decided it's better to take a smaller loss now by liquidating, than wait for a larger loss later and they're voting against the deal.

I can only hope!

Somethings fishy going on here. Why the sudden spike in volume? New buyer in sight?

Fun while it lasted.

Big bounce today. Anyone know why?

$700k / month for a company that has only a few execs and no business left???

No wonder they want to merge. If they liquidate, the execs all lose their gravy train.

Maybe that can be part of the class action suit.

Looks like an attempt to prevent the merger by some shareholders has failed. http://ih.advfn.com/p.php?pid=nmona&article=72839538&symbol=CBYL

Looks like an attempt to prevent the merger by some shareholders has failed. http://ih.advfn.com/p.php?pid=nmona&article=72839538&symbol=CBYL

Sadly, I don't think so.